DJIA 17,946.15 -91.82 -0.51%
NASDAQ 5,012.59 -47.66 -0.94%
S&P 500 2,098.84 -10.08 -0.48%
market minute promo

CLOVIS ONCOLOGY INC (NASDAQ: CLVS)

79.99 -3.72 (-4.44%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CLVS $79.99 -4.44%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $84.02
Previous Close $83.71
Daily Range $79.29 - $86.19
52-Week Range $35.33 - $94.88
Market Cap $2.7B
P/E Ratio -17.74
Dividend (Yield) $0.00 (0.0%)
Volume 152,765
Average Daily Volume 720,276
Current FY EPS -$7.55

Sector

Industry

CLOVIS ONCOLOGY INC (CLVS) Description

Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring developing and commercializing innovative anti-cancer agents in the United States Europe and additional international markets. Website: http://www.clovisoncology.com/

News & Commentary Rss Feed

Why Clovis Oncology, Inc. Is Soaring Higher Today

A key Wall Street upgrade sent shares in Clovis Oncology, Inc. higher today.

Clovis Oncology (CLVS) Falls: Stock Goes Down 5.3% - Tale of the Tape

J.P. Morgan's 3 Biotechnology Picks

Monday's ETF Movers: XBI, GDXJ

Clovis Oncology (CLVS) Stock Spikes Today on Analyst Upgrade

Benzinga's Volume Movers

Top Analyst Upgrades and Downgrades: Apple, BP, Hewlett-Packard, Philip Morris, UnitedHealth, AT&T a

Top Analyst Upgrades and Downgrades: Apple, BP, Hewlett-Packard, Philip Morris, UnitedHealth, AT&T and More

Benzinga's Top #PreMarket Gainers

Clovis Oncology (CLVS) in Focus: Stock Moves 8% Higher - Tale of the Tape

Clovis Oncology's Rucaparib Gets Breakthrough Status - Analyst Blog

See More CLVS News...